Filenews 19 September 2020
Evidence from the findings of the independent panel of experts investigating the unexplained disease experienced by volunteers in the UK who received the crown vaccine, jointly developed by Oxford University and biopharmaceutical company AstraZeneca, is provided by CNN.
According to the confidential document, the case of the 37-year-old volunteer who "showed confirmed transverse myelitis" after administering the second dose of the AZD1222 vaccine is described. The woman was admitted to hospital on September 5.
The report also describes how the patient had received the first dose of the vaccine in early June and was fine. She took the second installment in late August and while she was out of the house on September 2, running, "she had a jolt fall." According to the report she had no apparent spinal damage when examined by doctors, CNN claims.
The next day, she had difficulty walking, pain and weakness in her hands, pain and decreased sensation in the torso, headache and decreased ability to use her hands.
The report also states twice that the woman was diagnosed with "confirmed transverse myelitis," the US news network reports.
It is worth noting that nothing similar has been diagnosed in other volunteers taking part in the clinical trial of the vaccine, according to the experts. The neurologist who monitors the patient also notes in the report that, the woman is now starting to feel better.
The finding dated September 10 was sent to the doctors in charge of AZD1222's clinical development program on September 11, according to CNN.
AstraZeneca has already announced the resumption of clinical trials of the vaccine in the UK and Brazil, but not in the US. But according to dr. Anthony Fawci, director of the U.S. National Institute of Allergy and Infectious Diseases, said it's only a matter of time before clinical trials begin again in the U.S.
Source: protothema.gr
Kayıtlar
0 Comments:
Yorum Gönder